ArticleFrontiers in medicine2021

Topical Application of the PI3Kβ-Selective Small Molecule Inhibitor TGX-221 Is an Effective Treatment Option for Experimental Epidermolysis Bullosa Acquisita.

Hannah Zillikens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.